What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to announce the appointment of Robert A. Eckert as a new director to Amgen Inc.'s Board of Directors.

What relevant experience does Robert A. Eckert bring to Amgen's board?

Mr. Eckert brings substantial executive leadership experience, including serving as Chief Executive Officer of Mattel, Inc. from 2000 to 2011, and holding various senior leadership positions at Kraft Foods Group, Inc. He also has experience as a director on other public company boards, including McDonald's Corporation and Mattel, Inc.

What committees will Mr. Eckert serve on?

Mr. Eckert has been appointed to serve as a member of Amgen's Audit Committee and the Corporate Responsibility and Compliance Committee.

How will Mr. Eckert be compensated as a director?

Mr. Eckert will receive a prorated portion of the annual director retainer for the remainder of 2012, along with per-meeting fees. Effective January 1, 2013, the director compensation program was revised, providing an annual retainer of $100,000 and annual restricted stock unit grants with a grant date fair value of $200,000, which vest immediately.

AMGN 8-K: Leadership Changes

Summary

This Form 8-K filing by Amgen Inc. (AMGN) on December 13, 2012, primarily announces the appointment of Robert A. Eckert to its Board of Directors, effective immediately. Mr. Eckert brings extensive executive experience, having previously served as CEO of Mattel, Inc. and in various leadership roles at Kraft Foods. His appointment is significant as it adds a seasoned business leader to Amgen's governance. The filing also details Mr. Eckert's compensation and committee assignments. He will serve on the Audit Committee and the Corporate Responsibility and Compliance Committee. The report outlines his initial equity grant, prorated cash compensation for the remainder of 2012, and revised director compensation structure effective January 1, 2013, including an increased annual retainer and annual restricted stock unit grants. This indicates a strategic move to strengthen board oversight and compensation practices.

Key Highlights

1Amgen Inc. appointed Robert A. Eckert to its Board of Directors, effective December 13, 2012.
2Mr. Eckert has significant prior executive experience, including CEO roles at Mattel, Inc. and Kraft Foods Group, Inc.
3Mr. Eckert will serve as a member of the Audit Committee and the Corporate Responsibility and Compliance Committee.
4Upon appointment, Mr. Eckert received an initial stock option grant for 20,000 shares, with vesting contingent on Q4 2012 earnings release.
5Director compensation was revised effective January 1, 2013, with an increased annual retainer ($100,000) and annual restricted stock unit grants valued at $200,000.
6There are no disclosed related-party transactions involving Mr. Eckert.

AMGEN INC 8-K Report, Executive Changes (Dec 14, 2012)

Summary

Key Highlights

Frequently Asked Questions